Ever Glory United Holdings Ltd – Order Book Surges Past S$1bn September 4, 2026

Ever Glory United Holdings Ltd – Order Book Surges Past S$1bn

Brief Overview

Ever Glory United Holdings delivered strong 1H26 results, with revenue and adjusted profit after tax and minority interest (PATMI) exceeding expectations at 84% and 94% of full-year forecasts respectively. The company’s order book surged 220% year-on-year to more than S$1bn following the securing of over S$400mn in new contracts during 2026. Phillip Securities Research maintains a BUY recommendation with a raised target price of S$1.20.


Investment Positives

The primary driver of Ever Glory’s growth has been the consolidation of Guthrie’s results following the acquisition. The company’s adjusted PATMI accelerated 208% year-on-year to S$14.1mn in 1H26, compared to 98% growth in 2H25. This growth was driven by the consolidation and recognition of Guthrie’s mechanical and electrical (M&E) works, particularly progress on combined M&E projects including maintenance of street lighting and bus depot facility upgrades.

The company’s order book represents a significant positive, having surged more than 220% year-on-year to exceed S$1bn. Ever Glory secured more than S$400mn in new contracts during 2026, including S$168mn combined value for an offshore defence infrastructure project and M&E contracts in commercial mixed developments. This substantial order book is expected to support growth through 2029.

The company has also strengthened its financial position, with net debt reducing by 86% year-on-year to S$716,000, supported by a S$19mn year-on-year increase in operating cash flow. This improved balance sheet has enabled Ever Glory to recommend interim dividends of 0.75 cents per share, representing a 29% payout ratio, compared to no interim dividend in 1H25.


Investment Negatives

The report does not explicitly outline specific investment negatives or risks facing Ever Glory United Holdings.


Outlook

Ever Glory appears well-positioned for continued growth, with management believing the company can secure additional high-value M&E contracts. Potential future awards include Integrated General Hospital projects worth more than S$200mn per M&E project, Changi T5 buildings and runway lighting worth S$1bn or more for M&E work, and LTA MRT tunnel lighting projects.


Recommendation & Target Price

Phillip Securities Research maintains a BUY recommendation on Ever Glory United Holdings with a raised target price of S$1.20, increased from the previous target of S$1.05. The analysts raised FY26 revenue and PATMI forecasts by 57% and 62% respectively due to the consolidation of Guthrie’s results.


Frequently Asked Questions

Q: What drove Ever Glory's strong 1H26 performance?

A: The consolidation of Guthrie's results following acquisition drove the strong performance, with adjusted PATMI accelerating 208% year-on-year to S$14.1mn, supported by progress on combined M&E projects including street lighting maintenance and bus depot facility upgrades.

Q: How significant is the company's current order book?

A: The order book surged more than 220% year-on-year to exceed S$1bn, with the company securing over S$400mn in new contracts during 2026. This order book is expected to support growth until 2029.

Q: What types of new contracts has Ever Glory secured?

A: The company secured S$168mn combined value for an offshore defence infrastructure project and M&E contracts in commercial mixed developments as part of the over S$400mn in new contracts obtained in 2026.

Q: How has the company's financial position changed?

A: Ever Glory's balance sheet has strengthened significantly, with net debt reducing by 86% year-on-year to S$716,000, driven by a S$19mn year-on-year increase in operating cash flow.

Q: What dividend has the company declared?

A: Ever Glory recommended interim dividends of 0.75 cents per share, representing a 29% payout ratio, compared to no interim dividend in 1H25.

Q: What potential future contracts could the company secure?

A: Potential awards include Integrated General Hospital projects worth more than S$200mn per M&E project, Changi T5 buildings and runway lighting worth S$1bn or more for M&E, and LTA MRT tunnel lighting projects.

Q: How have the analysts' forecasts changed?

A: Phillip Securities Research raised FY26 revenue and PATMI forecasts by 57% and 62% respectively due to the consolidation of Guthrie's results, whilst increasing the target price from S$1.05 to S$1.20.

Ever Glory United Holdings Ltd – Order Book Surges Past S$1bn

This article has been auto-generated using PhillipGPT. It is based on a report by a Phillip Securities Research analyst.

 

Disclaimer
These commentaries are intended for general circulation and do not have regard to the specific investment objectives, financial situation and particular needs of any person. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. You should seek advice from a financial adviser regarding the suitability of any investment product(s) mentioned herein, taking into account your specific investment objectives, financial situation or particular needs, before making a commitment to invest in such products.

Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of units in any fund and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance.

Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com